Skip to content

Tectonic Therapeutics TECX Ratios & Valuation

Q1 '26Q4 '25Q3 '25Q2 '25Q1 '25
Returns
Return on equity-31.4%-37.8%-32.2%-29.3%
Return on assets-29.7%-0.9pp-35.8%+24.5pp-30.2%+8.1pp-27%+1.0pp-28.8%+20.9pp
Liquidity
Current ratio18.5×-4.4×26.6×+14.0×29.2×+19.8×25.6×+18.4×22.9×-3.3×
Quick ratio18.5×-4.4×26.6×+14.0×29.2×+19.8×25.6×+18.4×22.9×-3.3×
Cash ratio18.3×-4.4×26.3×+14.0×28.8×+19.5×25.3×+18.2×22.7×+17.2×
Leverage
Debt-to-equity0.0×0.0×0.0×0.0×
Debt-to-assets0.0×0.0×0.0×0.0×0.0×
Interest coverage-1,824.3×-1,157×-1,333.9×-787×-1,048.1×-596×-884×-544×-666.8×-361×
Per Share
Book value per share$12.28-30.0%$13.72-17.3%$14.30+40.0%$15.19-73.3%$17.55+124%
Valuation
Market capitalization$585.51M+58.3%$390.42M-42.7%$293.59M$376.62M$330.52M
Enterprise value$353.51M+438%$138.24M-74.5%$25.32M$90.6M$26.31M
Price / book2.5×+1.3×1.6×-3.3×1.1×1.3×1.1×
Free cash flow yield-11.2%+5.8pp-15.4%-6.7pp-21.3%-17.1%-19.1%
Earnings yield-14.3%+1.6pp-19%-10.5pp-22.9%-17.5%-17.8%

Chart any of these lines over time, or line them up against competitors.

Compare these in charts →

Questions, answered.

Where do Tectonic Therapeutics's ratios come from?
Every ratio is computed from Tectonic Therapeutics's SEC filings — trailing-twelve-month flows over period-end balances. Valuation multiples combine those fundamentals with market data, recomputed each period. Switch between quarterly, annual, and TTM, or open any ratio for its full history and peer comparisons.